Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease (ASSURE)
This study is ongoing, but not recruiting participants.
Study NCT01583608 Information provided by Medical Care Center Prof. Mathey, Prof. Schofer, Ltd.
First Received on April 17, 2012. Last Updated on March 20, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Coronary Artery Disease
Arterial Occlusive Diseases
Additional conditions recognized in this trial
More general conditions related to this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Physiological Effects of Drugs
Sponsors listed in this trial
Medical Care Center Prof. Mathey, Prof. Schofer, Ltd.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers